Evan Chen
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Blood groups and transfusion
-
- Venous Thromboembolism Diagnosis and Management
Papers in
- Hematology 32
- Acute Myeloid Leukemia Research 25
- Chronic Myeloid Leukemia Treatments 8
- Hematopoietic Stem Cell Transplantation 5
- Genetics 13
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Co-authors
- Andrew Mark Brunner (4 shared papers)Amir Tahmasb Fathi (4 shared papers)Jacqueline Suen Garcia (8 shared papers)Nathan T. Connell (4 shared papers)Jean M. Connors (3 shared papers)Rebecca L. Zon (3 shared papers)Rebecca Marlene Baron (2 shared papers)Richard Maury Stone (7 shared papers)
- Journals
- Blood Advances (10 papers)Blood (6 papers)Bone Marrow Transplantation (2 papers)Leukemia (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Evan Chen
44 papers receiving 472 citations
Peers
Comparison fields: 5 of 58
- Hematology 233
- Internal Medicine 29
- Genetics 68
- Oncology 92
- Infectious Diseases 60
Countries citing papers authored by Evan Chen
This map shows the geographic impact of Evan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Chen more than expected).
Fields of papers citing papers by Evan Chen
This network shows the impact of papers produced by Evan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Chen. The network helps show where Evan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 72 | |
| 2 | 2018 | 46 | |
| 3 | 2015 | 37 | |
| 4 | 2017 | 35 | |
| 5 | 2022 | 28 | |
| 6 | 2024 | 24 | |
| 7 | 2016 | 22 | |
| 8 | 2024 | 20 | |
| 9 | 2024 | 20 | |
| 10 | 2024 | 19 | |
| 11 | 2021 | 15 | |
| 12 | 2022 | 11 | |
| 13 | 2023 | 10 | |
| 14 | 2022 | 10 | |
| 15 | 2024 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2018 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2024 | 7 | |
| 20 | 2022 | 6 |
About Evan Chen
Evan Chen is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 52 papers that have together received 484 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (25 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), CAR-T cell therapy research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers), COVID-19 Clinical Research Studies (3 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Hematology (233 citations), Internal Medicine (29 citations), Genetics (68 citations), Oncology (92 citations) and Infectious Diseases (60 citations). Evan Chen has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Andrew Mark Brunner, Amir Tahmasb Fathi, Jacqueline Suen Garcia, Nathan T. Connell, Jean M. Connors, Rebecca L. Zon, Rebecca Marlene Baron, Richard Maury Stone, Matthew D. Moll and Maximilian F. Stahl. Their work appears in journals such as Blood Advances, Blood, Bone Marrow Transplantation, Leukemia and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.